Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, ...
ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal ...
ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review ...
Operator: Good day, everyone, and thank you for standing by. My name is RG, and I will be your conference operator today.
If you have lived with pain for months, you have likely heard of tramadol. Many people consider it a gentler opioid that ...
First up, Johnson swings into Holmdel, NJ’s PNC Bank Arts Center on Sunday, June 21. After that, he’ll hit Saratoga Springs’ ...
PRESS RELEASE Memo Therapeutics AG Presents Long Term Follow-Up Data from its Phase II SAFE KIDNEY Trial of Potravitug and ...
SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J., November 07, 2025--Kardigan, a heart health company modernizing cardiovascular ...
ELATIVE long-term open label extension trial demonstrate sustained biochemical response, stabilization of fibrosis markers ...
The rapper, who has become one of hip-hop’s leading stars, presided over a sweaty tangle of young men outfitted in black and ...
Dave Hedeman and Justin Bowlin of the Gone Ghosts stopped by Live & Local this week, ahead of the release of their new EP, ...
Recorded live at the Dolby Theatre in Los Angeles, Wicked: One Wonderful Night (Live) – The Soundtrack captures performances ...